Drug Shortage Report for POTASSIUM ACETATE INJECTION USP
Report ID | 98415 |
Drug Identification Number | 02362597 |
Brand name | POTASSIUM ACETATE INJECTION USP |
Common or Proper name | Potassium Acetate Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | POTASSIUM ACETATE |
Strength(s) | 39.2% |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS |
Packaging size | 10 x 50mL vial / fiole |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-09 |
Estimated end date | 2019-12-15 |
Actual end date | 2019-12-19 |
Shortage status | Resolved |
Updated date | 2020-01-08 |
Company comments | On allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-01-08 | French | Compare |
v3 | 2020-01-08 | English | Compare |
v2 | 2019-11-11 | French | Compare |
v1 | 2019-11-11 | English | Compare |
Showing 1 to 4 of 4